GKB Ophthalmics valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY23Mar 2023
Price multiples — at each FY-end close
1.10×—
1.09×—
Enterprise multiples
1.49×—
−37.76×—
−11.39×—
Yield
0.0%—
−9.5%—
−6.5%—
Reference — adjusted share basis
₹60.01—
−₹5.72−₹5.72
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GKB₹60.01

GKB Ophthalmics Limited

· Pharma & Health
₹ CrorePeersFABTECHLAXMIDENTLTARSONSFISCHERMcap ₹30.2 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
Current
last close
Price Multiples — at each FY-end close
P/B—1.10
P/Sales—1.09
Enterprise Multiples
EV/Sales—1.49
EV/EBITDA—-37.76
EV/EBIT—-11.39
Yield
Dividend Yield %—0.00
Earnings Yield %—-9.53
FCF Yield %—-6.48
Reference — adjusted share basis
Price (FY-end close, adj.)—60.01
EPS (adj.)-5.72-5.72
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.